Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

HARVARD BIOSCIENCE INC Director's Dealing 2008

Dec 23, 2008

34975_dirs_2008-12-23_2836b849-4cd1-4af5-9f1b-9d875c6294dd.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: HARVARD BIOSCIENCE INC (HBIO)
CIK: 0001123494
Period of Report: 2008-12-19

Reporting Person: GREEN DAVID (Director, President)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2008-12-19 Common Stock P 100 $2.37 Acquired 1399873 Direct
2008-12-19 Common Stock P 800 $2.38 Acquired 1400673 Direct
2008-12-19 Common Stock P 1700 $2.39 Acquired 1402373 Direct
2008-12-19 Common Stock P 5300 $2.4 Acquired 1407673 Direct
2008-12-19 Common Stock P 100 $2.46 Acquired 1407773 Direct
2008-12-19 Common Stock P 600 $2.47 Acquired 1408373 Direct
2008-12-19 Common Stock P 100 $2.48 Acquired 1408473 Direct
2008-12-19 Common Stock P 600 $2.49 Acquired 1409073 Direct
2008-12-19 Common Stock P 700 $2.50 Acquired 1409773 Direct
2008-12-22 Common Stock P 100 $2.50 Acquired 1409873 Direct
2008-12-22 Common Stock P 400 $2.44 Acquired 1410273 Direct
2008-12-22 Common Stock P 9500 $2.45 Acquired 1419773 Direct

Footnotes

F1: Purchased pursuant to a stock trading plan established in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.